SAMSUNG BIOLOGICS TO START MRNA VACCINE PRODUCTION LINE

Highlights:

• Samsung Biologics, a South Korean drugmaker, is planning to open an mRNA vaccine production line at its facility in Songdo.
• Messenger RNA or mRNA vaccines are known for their safety and fast scalability in manufacturing. 
• The company will enable end-to-end mRNA vaccine manufacturing services from bulk drug substances.

Samsung Biologics, a South Korean d....